Molly Gilmartin

Great post! In summary: Don't give up hope of selling to the NHS, but tell founders to: 1️⃣ Prepare for the long run. 2️⃣ Prioritise developing evidence for your solutions. 3️⃣ Develop great assets that communicate your product's value proposition. Thanks Dr. Zhong Wei Khor!

3

Is the UK viable for HealthTech Start-ups? Yes and No. Yes - If you are looking to build and validate well. No - If you only have very short timeframes. I speak to quite a few international companies and founders looking to expand within the UK via Adopt-A-Doc. Inevitably I am asked the question above. 𝐋𝐞𝐭'𝐬 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫 𝐭𝐡𝐞 𝐩𝐫𝐨𝐬 𝐚𝐧𝐝 𝐜𝐨𝐧𝐬. ✅ 𝐏𝐫𝐨𝐬: - There are quite a few grants to support early stage companies. - NICE and NHS endorsement carry significant weight globally. - There are plenty of reputable academic institutions to partner with. - MHRA regulatory status, like the FDA, is globally recognised.  - There is a very strong healthtech community within the UK. ❌ 𝐂𝐨𝐧𝐬: - Much higher cost to entry and development.  - Significantly more regulatory barriers and standards to comply. - Timelines are protracted be it in academia, NHS or industry. - The NHS is under tremendous budgetary constraints. - There are many incumbents in place, competition is fierce. 🤔 𝐒𝐭𝐚𝐫𝐭-𝐮𝐩𝐬 𝐚𝐥𝐬𝐨 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐜𝐨𝐧𝐬𝐢𝐝𝐞𝐫: - Are there established procurement frameworks or pots of money for similar technologies? - Are there specific grants or academic institutions that can partner with you? - Does your product currently align with the goals and priorities of the NHS? 🌞 𝐎𝐧𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐯𝐞 𝐩𝐨𝐢𝐧𝐭 𝐈 𝐡𝐚𝐯𝐞 𝐭𝐨 𝐦𝐚𝐤𝐞 𝐢𝐬 𝐭𝐡𝐚𝐭: - Compared to many other countries, the UK genuinely has a supportive ecosystem to help healthtech innovators. The Health Innovation Network, NHS Innovation Accelerator, Digital Health Playbook, ABHI (Association of British HealthTech Industries), NIHR (National Institute for Health and Care Research), NICE - National Institute for Health and Care Excellence, Accelerators like Propel@YH and DigitalHealth.London Are all examples of tangible support. (Few countries have all the above) ____________________________________ There is never a right or wrong answer. Each founder have to make the call for themselves. But this is my take so far. 😁 🤔 What do you think? Yes or No? 👇 Do share your thoughts below! Liz Ashall-Payne | Hassan Chaudhury HonFAPM | Kevin McDonnell | Nina Sesto, PhD | Liam Cahill | Madhukar Bose |

155

70 Comments

🎯 Cracking the NHS code: How health tech can succeed NIHR’s Vee Mapunde talks about the biggest opportunities for health tech in the NHS and shares advice for innovators on providing evidence, engaging users, and accelerating adoption. Check out the interview 👉 https://bit.ly/3Yav1pi #DigitalHealth #NHSInnovation #HealthTech #NIHR #TechInCare #MedTech

11

The dust is settling as the new government starts its term in the UK. But the need to transform the NHS remains the same, with the same drastic need to improve healthcare and increasing demand to address social care needs necessitated by the changing demographics of the country. Dealmakers say there are indications of a growing increase in M&A in the healthcare sector this year, as Murat Basboga reports Full details - the forward looking plans, financials and advisors - can be found in our article, which is live on HealthInvestor (behind paywall): https://lnkd.in/eDdAEbWi If you're not yet a subscriber, you can follow this link to find out options: https://lnkd.in/eQVEeWGX #healthcare #socialcare #MergersAndAcquisitions 

7

Day Zero dispatchs from HLTH Europe For an event that hadn't officially opened yet, there was a huge amount going on yesterday. Adequately fueled and hydrated, your intrepid avatar launched into the festivities. What were some of the highlights? HealthXL hosted an event looking at AI in Lifesciences and Pharma. They always draw a huge crowd on leaders from industry, and today was no different. Chandana Fitzgerald started with the news that they have merged with HLTH, becoming HLTH Community! Robert Garber led with a VC summary of the state of AI, and how to avoid the infamous Trough of Disillusionment. With 82% of companies looking to implement AI governance, it's a good time for those looking to make AI safe and effective. Unsurprisingly, hes also seeing greatest focus on the less complex, administrative side of healthcare. Cristina Ortega Duran gave a lively presentation on their successes with Evinova, which integrates trail data into a single platform. Stephen R. called on the audience to follow 3 rules: focus on the customer problem first, learn quickly, and follow the evidence. Yes, he's turning everyone into Product Managers. During the panel we had great questions about bias and representation from Aahuti Rai, which underlined the role that synthetic data and telehealth have to play in filling gaps and reducing the burden of trial participation. The final workshop focussed on priority use cases for AI in Drug R&D and Clinical Development. Some suggestions included Ambient Documentation for researchers, summarisation of content translation to ease recruitment, and the identification of novel outcome metrics. Shout out to whoever arranged the "AI in the NHS" session, because it was packed to overflowing. If anyone was lucky enough to find a seat, let me know how it went because I couldn't get in! After hours we had the customary networking events, including a brilliant get together from AlbionVC (thank you Molly Gilmartin!) where I finally got my chance to meet with Hello Self's Charles Wells, reconnect with AI legend and founder of Newton's Tree Haris Shuaib, Kelly Klifa & Alexandra (Sasha) T. from Ally Health, Samantha Fay from SiSU Health UK, and welcome back Dr. James Somauroo & Jessica Somauroo after their 5 week honeymoon. Given how hard they work, the absolutely deserved it. For all the clenched teeth and hair pulling that our industry can cause, today showed that the determination and drive to fix the problems we face are still there. HLTH really does know how to bring all the boys (and girls) to the yard! ALSO: Shout out to my former Babylon colleagues Nirvana Luckraj Darshak Sanghavi and Tom Breeze. The network remains *strong* #hltheurope #healthcare #innovation #digitalhealth #healthtech

136

9 Comments

Building a healthtech business before really validating your idea is insane. But yet, I see this all the time. As part of the work that I do with Adopt-A-Doc, I speak to lots of early stage healthtech founders. You will be genuinely surprised at how many dive right into the health space based off only on: 1. Desk research 2. Personal experience. 3. Feedback from 𝐨𝐧𝐞 clinician. What results is someone who only understand the macro picture, but without an inkling of the realities on the ground. This leads to a weak value proposition. And a poorly formed product. (That does not help anyone) ______________________________ In healthcare, validations comes in 3 levels. 𝐋𝐞𝐯𝐞𝐥 1: 𝐃𝐨𝐞𝐬 𝐢𝐭 𝐬𝐨𝐥𝐯𝐞 𝐚𝐧 𝐚𝐜𝐭𝐮𝐚𝐥 𝐩𝐫𝐨𝐛𝐥𝐞𝐦? - Is there a genuine clinical need for this? - Is there no current solutions to this? - Is this a big enough problem? 𝐋𝐞𝐯𝐞𝐥 2: 𝐇𝐨𝐰 𝐰𝐢𝐥𝐥 𝐭𝐡𝐞 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐟𝐢𝐭 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐛𝐢𝐠𝐠𝐞𝐫 𝐩𝐢𝐜𝐭𝐮𝐫𝐞? - Can it work in the current clinical pathway? - Is it technically feasible with current infrastructure? - Will the solution work in other regions as well? 𝐋𝐞𝐯𝐞𝐥 3: 𝐖𝐢𝐥𝐥 𝐩𝐞𝐨𝐩𝐥𝐞 𝐚𝐜𝐭𝐮𝐚𝐥𝐥𝐲 𝐩𝐚𝐲 𝐟𝐨𝐫 𝐭𝐡𝐢𝐬? - Is there reimbursement pathways for similar tools? - Is there genuine appetite to pay for your solution? - What are the barriers to payment and market entry? ______________________________ 𝐓𝐡𝐞 𝐭𝐫𝐮𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐭𝐭𝐞𝐫 𝐢𝐬, There is really no excuse for anyone not to take the time and effort to find out the basics as above. Healthcare is a slow and expensive industry to innovate in. Mistakes are also less tolerated as well. Wouldn't it be sensible to find out the above before betting the house and starting a whole business? 🤔 Just my 2 cents. 👇 What do you think? Priya Oberoi | Estia Ryan | Kevin McDonnell | Konrad Dobschuetz | Hassan Chaudhury HonFAPM | Ezzaldeen Elzagzoug | Dr Thomas Maggs

101

32 Comments

Privileged and exited to be one of the mentors for the Accelerating FemTech programme . 21 of the best start-ups, university spinouts and entrepreneurial-minded academics who have early-stage innovations for women’s health. These innovations have the potential to address urgent challenges in women’s health, including menstruation management, maternity and neonatal safety, menopause management and sexual health. LinkedIn: https://lnkd.in/dhfA3K4d #AcceleratingFemTech

28

2 Comments

📣 Since 2018, our support to innovators has leveraged £2.6 billion for the UK economy. Find out how innovation can drive economic prosperity and growth in this new blog ➡ https://lnkd.in/e26aVPuE #HealthInnovationWorks Health Innovation East

42

💥 Today we officially announce our collaboration with the University of Southampton’s School of Cancer Sciences! 🤝 The partnership combines Evariste’s AI modelling capabilities with Southampton’s clinical data to generate one of the largest-known transcriptomic datasets in oesophageal adenocarcinoma (OAC). 💊 OAC is a cancer with incredibly limited therapeutic options, and has no targeted therapies as part of the current standard of care. The dataset formed from this collaboration will drive the discovery of novel therapeutic targets for this challenging cancer with the use of Evariste’s Frobenius Target platform. 📰 Read the full press release here: https://lnkd.in/eqKV76Sf #Evariste #UniversityOfSouthampton #OAC #OesophagealAdenocarcinoma #EsophagealAdenocarcinoma #SyntheticLethality #AIDrugDiscovery #TargetID #Collaboration #Transcriptomics

89

Proud to see our very own Matt Williams and Guy Checketts featured in The Guardian in a series of articles exploring digital therapeutics and the challenges of bringing them to market. We’re sharing key insights on navigating NHS adoption and other critical hurdles in the journey to success. Read the full articles for expert advice! https://lnkd.in/eeCxgzTd #DigitalHealth #HealthcareInnovation #DTx #TheGuardian

12

🚀 Funding Opportunity: Innovate UK’s Digital Therapeutic XR for Mental Health Programme 🚀 Innovate UK is investing up to £3.7 million in projects developing digital therapeutic extended reality (XR) solutions to support mental healthcare services. This programme aims to advance innovative XR applications that can be scaled as part of the UK’s formal mental healthcare ecosystem. 🔹 Funding Available: £200,000 - £300,000 per project 🔹 Deadline: Wednesday 15 January 2025, 11:00 am UK time 🔹 Eligibility: UK-registered organisations developing XR-based digital therapeutic solutions for mental health Project Requirements XR Application in Mental Health: Create digital therapeutic solutions using XR, including VR, AR, mixed reality, haptics, immersive audio, and holograms. Focus on Moderate to Severe Mental Health Conditions: Develop solutions that provide real-world benefits for those living with moderate to severe mental health challenges, improving quality of life, employment, and daily activities. Scalable Solutions Across Clinical Levels: Propose solutions suitable for any stage in the care pathway with a clear potential for regulatory approval and wide-scale adoption. Acclivity Ventures offers expert grant-writing support to help UK organisations craft high-quality applications, boosting their chances of securing funding and making a real impact in mental healthcare innovation. https://lnkd.in/eEiFCEJZ

1

AI is transforming healthcare, and Steve Russell Managing Director of BigHand Healthcare, calls it a “game changer.” In the third episode of Under the Microscope, Steve Russell discusses how healthcare leaders are responding to the potential of A, signalling that we are on the cusp of something transformative for the NHS. We’re pleased to share this episode as our partnership with BigHand is set to bring an AI copilot to 40,000 NHS healthcare workers, transforming care without disrupting workflows. Watch the full episode: https://hubs.li/Q02YzFN30

44

Steve Russell, Managing Director of Healthcare, discusses our partnership with Corti, set to benefit 40,000 NHS Healthcare workers through a new AI tool that reduces admin time by 80% 🏥📈 To learn more about the partnership, visit 👉 https://lnkd.in/gkFGnHQn

6

1 Comment